This Ivermectin News could change EVERYTHING for fighting cancer

About this video

• Video Title: This Ivermectin News could change EVERYTHING for fighting cancer
• Channel: Redacted
• Speakers: Nicholas Hulscher, Clayton Morris, Natali Morris
• Duration: 00:31:32

Overview

This video discusses a new study on ivermectin and mebendazole as potential cancer treatments. The study, presented by Nicholas Hulscher of the McCullough Foundation, suggests significant tumor regression and disappearance in patients. The discussion also touches upon the historical suppression of information regarding anti-parasitics and cancer, the high costs and limited effectiveness of conventional chemotherapy, and the potential for ivermectin and mebendazole as safer, more affordable alternatives.

Key takeaways

• A recently published study indicates that nearly half of cancer patients experienced tumor disappearance or significant regression after six months of treatment with ivermectin and mebendazole.
• The study's authors claim ivermectin targets cancer stem cells, while mebendazole disrupts microtubule function and glucose metabolism in cancer cells.
• The video suggests that information about the anti-cancer properties of antiparasitics may have been suppressed for decades to protect the profits of the pharmaceutical industry and chemotherapy.
• Conventional chemotherapy is presented as extremely expensive, with a low clinical benefit ratio, and often causes severe side effects by damaging healthy cells.
• Ivermectin, a Nobel Prize-winning drug for parasitic infections, is highlighted for its safety profile and potential for non-patentable, low-cost treatments.
• The study included patients with various cancer types and stages, including advanced metastatic cancer, showing promising results across the board.
• Future research, including large-scale, randomized, double-blind placebo-controlled trials, is needed to further validate these findings and potentially change cancer treatment guidelines.